Press Releases
  Date Title and Summary View
Jan 26, 2018
WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 25, 2018. This dividend is payable on May 10, 2018 to all shareholders of record at the close of business on April 13, 2018. ...
PDF
Jan 25, 2018
Fourth Quarter 2017 GAAP revenue growth of 13% to $642 million; 6% organic revenue growth excluding EUROIMMUN Fourth Quarter 2017 GAAP losses per share from continuing operations of $0.35; Adjusted earnings per share of $0.97, an increase of 17% Completes...
PDF
Jan 5, 2018
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced today announced that on Thursday, January 25, 2018, after market close, the Company will release fourth quarter 2017 results. The Company will also host a confer...
PDF
Dec 27, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the J.P. Morgan 36th Annual Healthcare Conference on Wednesday, January 10, 2018 at 8:00 am PT at the Westin St. Francis Hotel i...
PDF
Dec 19, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acquisition of EUROIMMUN Medical Laboratory Diagnostics AG. PerkinElmer originally announced its...
PDF
Dec 5, 2017
PDF
Nov 21, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Citi Global Healthcare Conference on Wednesday, December 6, 2017 10:15 a.m. ET at the Lotte New York Palace in New York City...
PDF
Nov 2, 2017
GAAP revenue growth of 8% to $554 million; 5% organic revenue growth GAAP earnings per share from continuing operations of $0.87; Adjusted earnings per share of $0.73, an increase of 14% GAAP operating margin of 14.4%; Adjusted operating margins expand by 30 basis p...
PDF
Oct 31, 2017
Key Discoveries in the Therapeutic Application of Cord Blood: Improvement of Motor Function in Children with Cerebral Palsy WALTHAM, Mass.--(BUSINESS WIRE)-- Research published in Stem Cells Translational Medicine shows encouraging developments related to using a child's own cord ...
PDF
Oct 30, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world , today announced that Pascale Witz, MBA, MSc, has been elected to its Board of Directors, effective immediately. "We would like to extend a warm welcome to Pascal...
PDF
Page:
1
... NextLast